PHAR-RWEB0010 - Pharmacy - Recorded Webinars

Presented by Dr. Kyle Wilby, Dr. Tasha Ramsey, Kenzie d’Entremont-Harris, Greg Richard

This session will provide an overview of pre-exposure prophylaxis (PrEP) for HIV and the potential role of a pharmacist as a PrEP prescriber. Presenters will review HIV epidemiology and risk factors, the availability and pharmacological considerations of PrEP, and a prescribing protocol that includes monitoring and assessment of patient eligibility and laboratory values. By the end of the session, participants will be able to follow a protocol for PrEP prescribing as part of a collaborative practice agreement or independent prescribing if approved in Nova Scotia.

We recommend you use Google Chrome or Mozilla Firefox to access this webinar. Safari and Internet Explorer are known to provide unstable connections to our webinar platform.

For support, please email dalcpe@dal.ca

Presented by Greg Richard

Learning Objectives:

1. Explore the epidemiology of gender diversity in Canada. 

2. Briefly discuss the assessment strategies used in initiating gender affirming care.  

3. Describe non-pharmacological strategies and pharmacological therapies used in gender affirmation.  

4. Review practical considerations for providing gender affirming care in clinical practice.

We recommend you use Google Chrome or Mozilla Firefox to access this webinar. Safari and Internet Explorer are known to provide unstable connections to our webinar platform.

For support, please email dalcpe@dal.ca

Presented by Kelly MacKinnon, Jennifer Fleming, and Madi McLean

Learning objectives

1. Identify best practices for the management of common community-acquired infections based on current evidence, local antimicrobial susceptibilities, and antimicrobial stewardship (AMS) principles. 
2. Discuss antimicrobial treatment options in adult & pediatric populations. 
3. Acquire local and Canadian AMS resources available to primary care providers across Nova Scotia. 

We recommend you use Google Chrome or Mozilla Firefox to access this webinar. Safari and Internet Explorer are known to provide unstable connections to our webinar platform.

For support, please email dalcpe@dal.ca

Presented by:

Beverley Zwicker, CEO & Registrar  
Eric Coates, Director of Professional Services 
Meghan Campbell, Quality Assurance Assistant Manager 
Leah Hutt, Director of Policy and Registrations 

The webinar will provide an opportunity for pharmacy professionals to come together to learn about ongoing and upcoming NSPR initiatives: 

• New pharmacy legislation - an overview of the new consolidated Pharmacy Regulations and the approach the NSPR will now take in enabling pharmacists and pharmacy technicians to practice to their fullest potential 
• Staffing and Workload Initiative for Safety and Effectiveness (StaffWISE) - an update on the NSPR’s recently launched staffing level program 

We recommend you use Google Chrome or Mozilla Firefox to access this webinar. Safari and Internet Explorer are known to provide unstable connections to our webinar platform.

For support, please email dalcpe@dal.ca

Presented by Dr. Cindy Yeung

Each year, 60 in 15,000 newborns at the Neonatal Intensive Care Unit (NICU) in Canada experience adverse drug reactions due to off-label use (the drugs are not approved in neonates). The heavy impact of off-label drugs on neonates is not surprising since 90% of NICU drugs are used off-label in Canada. As another striking statistic, 22,100 mothers (10%) annually in Canada discontinue their drug therapy or breastfeeding due to uncertainty about how their medications might affect their infant. Similar to newborns, there is sparse labelling during lactation. 

Dr. Yeung's expertise in two model types, population PK (popPK) and physiologically based PK (PBPK) modeling, will help predict precise doses for neonates at the NICU and estimate maternal chemical exposures to breastfeeding infants. In this webinar, Dr. Yeung will be discussing how she plans to leverage these two modeling techniques in relation to cardiovascular health, environmental toxicology, and precision dosing.

We recommend you use Google Chrome or Mozilla Firefox to access this webinar. Safari and Internet Explorer are known to provide unstable connections to our webinar platform.

For support, please email dalcpe@dal.ca

Presented by Dr. Allison Scott

Grand Rounds presentation on ocular conditions that may require referral to optometry.  We will review which symptoms to listen for to develop a collaborative approach between optometry and pharmacy.

We recommend you use Google Chrome or Mozilla Firefox to access this webinar. Safari and Internet Explorer are known to provide unstable connections to our webinar platform.

For support, please email dalcpe@dal.ca

Presented by Dr. Sophie Church

At the end of this webinar, participants will be able to 

1. Describe the core symptoms, diagnostic criteria, and epidemiology of ADHD across the lifespan. 

2. Apply current guideline recommendations to optimize ADHD treatment in pharmacy practice. 

3. Compare stimulant and non-stimulant medications for ADHD with respect to mechanisms of action, delivery systems, efficacy, and adverse effects. 
4. Recognize important adverse effects, safety warnings, and monitoring requirements associated with ADHD medications. 

We recommend you use Google Chrome or Mozilla Firefox to access this webinar. Safari and Internet Explorer are known to provide unstable connections to our webinar platform.

For support, please email dalcpe@dal.ca

Presented by Dr. Sophie Church

At the end of this webinar, participants will be able to: 

1. Apply evidence-based strategies to manage common clinical scenarios in patients receiving treatment for ADHD. 
2. Identify safety considerations related to ADHD medications in clinical practice, and strategies to mitigate risk of harm. 
3. Differentiate approaches to ADHD management in the presence of comorbid conditions such as anxiety, depression, or substance use disorder.

4. Identify safety considerations related to ADHD medications in clinical practice, and strategies to mitigate risk of harm. 

We recommend you use Google Chrome or Mozilla Firefox to access this webinar. Safari and Internet Explorer are known to provide unstable connections to our webinar platform.

For support, please email dalcpe@dal.ca

Presented by Lisa Grandy Allen

At the end of this webinar, participants will be able to: 

1. Analyze the evolution of Canadian MAID legislation and ongoing debates
2. Review the ideal pharmacological properties for MAID medications and outline those included in current protocols
3. Detail logistical considerations for MAID prescriptions
4. Provide resources for MAID information and support

We recommend you use Google Chrome or Mozilla Firefox to access this webinar. For support, please email dalcpe@dal.ca